Outcomes of listing for lung and heart-lung transplantation in pulmonary hypertension: comparative experience in France and the UK

Lung or heart-lung transplantation (LT/HLT) for severe pulmonary hypertension (PH) as the primary disease indication carries a high risk of waiting list mortality and post-transplant complications. France and the UK both have coordinated PH patient services but with different referral pathways for accessing LT services. We conducted a comparative analysis of adult PH patients listed for LT/HLT in the UK and France. We included 211 PH patients in France (2006-2018) and 170 in the UK (2010-2019). Cumulative incidence of transplant, delisting and waiting list death within 3 years were 81%, 4% and 11% in France 58%, 10% and 15% in the UK (p